EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Bone proteins are associated with cardiovascular risk according to the SCORE2-Diabetes algorithm

Sheila González-Salvatierra, Antonia García-Martín, Beatriz García-Fontana, Luis Martínez-Heredia, Cristina García-Fontana, Manuel Muñoz-Torres

Cardiovascular Diabetology · 2024

DOI: 10.1186/s12933-024-02406-9 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cardiovascular Diabetology, 2024. Verfasst von Sheila González-Salvatierra und 5 weiteren Autor:innen. Beteiligte Einrichtung: Instituto de Investigación Biosanitaria de Granada (ibs.GRANADA), Granada, 18012, Spain. sgsalvatierra@ugr.es. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Cardiovascular Diseases, Biomarkers, Algorithms. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Instituto de Salud Carlos III, Junta de Andalucía, Centro de Investigación Biomédica en Red Enfermedades Cardiovasculares.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Typical bone proteins, such as sclerostin and periostin, have been associated with cardiovascular disease (CVD). Simultaneously, several risk scores have been developed to predict CVD in the general population. Therefore, we aimed to evaluate the association of these bone proteins related to CVD, with the main vascular risk scales: Framingham Risk Score (FRS), REGICOR and SCORE2-Diabetes, in patients with type 2 diabetes. We focus in particular on the SCORE2-Diabetes algorithm, which predicts 10-year CVD risk and is specific to the study population. METHODS: This was a cross-sectional study including 104 patients with type 2 diabetes (62 ± 6 years, 60% males). Clinical data, biochemical measurements, and serum bioactive sclerostin and periostin levels were collected, and different risk scales were calculated. The association between bioactive sclerostin or periostin with the risk scales was analyzed. RESULTS: A positive correlation was observed between circulating levels of bioactive sclerostin (p 131 pmol/L showed 51.6% sensitivity and 78.6% specificity. Similarly, serum periostin levels > 1144 pmol/L had 64.5% sensitivity and 76.2% specificity. CONCLUSIONS: Sclerostin and periostin are associated with vascular risk in the SCORE2-Diabetes algorithm, opening a new line of investigation to identify novel biomarkers of cardiovascular risk in the type 2 diabetes population.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2Cardiovascular DiseasesBiomarkersAlgorithmsAdaptor Proteins, Signal TransducingPredictive Value of TestsHeart Disease Risk FactorsHumansMaleMiddle AgedFemaleCross-Sectional StudiesRisk AssessmentAgedPrognosisGenetic MarkersCell Adhesion MoleculesDecision Support Techniques

Stichwörter der Autor:innen

BiomarkerBone proteinsCardiovascular disease riskPeriostinSCORE2-DiabetesSclerostinType 2 diabetes

Substanzen

POSTN protein, humanSOST protein, humanBiomarkersAdaptor Proteins, Signal TransducingGenetic MarkersCell Adhesion Molecules

Autor:innen und Institutionen

  • Instituto de Investigación Biosanitaria de Granada (ibs.GRANADA), Granada, 18012, Spain. sgsalvatierra@ugr.es.
  • Institute of Health Carlos III, CIBER of Frailty and Healthy Aging (CIBERFES), Madrid, 28029, Spain. sgsalvatierra@ugr.es.
  • Institute of Health Carlos III, CIBER of Frailty and Healthy Aging (CIBERFES), Madrid, 28029, Spain. garciamartin_t@hotmail.com.
  • Endocrinology and Nutrition Unit, University Hospital Clínico San Cecilio, Granada, 18016, Spain. garciamartin_t@hotmail.com.
  • Department of Medicine, University of Granada, Granada, 18016, Spain. garciamartin_t@hotmail.com.
  • Instituto de Investigación Biosanitaria de Granada (ibs.GRANADA), Granada, 18012, Spain.

Förderung

  • Instituto de Salud Carlos III
  • Junta de Andalucía
  • Centro de Investigación Biomédica en Red Enfermedades Cardiovasculares

Zitieren

APA

González-Salvatierra, S., García-Martín, A., García-Fontana, B., Martínez-Heredia, L., García-Fontana, C., & Muñoz-Torres, M. (2024). Bone proteins are associated with cardiovascular risk according to the SCORE2-Diabetes algorithm. Cardiovascular Diabetology. https://doi.org/10.1186/s12933-024-02406-9

Vancouver

González-Salvatierra S, García-Martín A, García-Fontana B, Martínez-Heredia L, García-Fontana C, Muñoz-Torres M. Bone proteins are associated with cardiovascular risk according to the SCORE2-Diabetes algorithm. Cardiovascular Diabetology. 2024. doi:10.1186/s12933-024-02406-9

BibTeX
@article{GonzlezSalvatierra2024,
  author = {González-Salvatierra, Sheila and García-Martín, Antonia and García-Fontana, Beatriz and Martínez-Heredia, Luis and García-Fontana, Cristina and Muñoz-Torres, Manuel},
  title = {Bone proteins are associated with cardiovascular risk according to the SCORE2-Diabetes algorithm},
  journal = {Cardiovascular Diabetology},
  year = {2024},
  doi = {10.1186/s12933-024-02406-9}
}
Kostenlos starten →